Literature DB >> 4198107

Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.

R M Bassiri, R D Utiger.   

Abstract

To study the metabolism of thyrotropin-releasing hormone (TRH) in vivo, 400 mug TRH was administered intravenously to eight normal male subjects. Multiple plasma and urine samples were obtained before and after TRH administration. Serum TSH concentrations increased after TRH administration in all subjects. Plasma TRH levels, measured by radioimmunoassay, were undetectable (< 0.4 ng/ml) before TRH administration. Plasma TRH concentrations averaged 33+/-7 ng/ml (mean +/-SEM) 2 min after TRH injection. Thereafter, they decreased rapidly so that the mean plasma TRH level was 2.9 ng/ml 20 min after TRH administration. The fall in plasma TRH levels was linear during this interval. Thereafter TRH levels declined more slowly. The mean half-life (t(1/2)) of TRH was 5.3+/-0.5 min. The mean distribution volume was 15.7+/-3.8 liters, an average of 16.5% of body weight in these subjects. In the urine, 5.5+/-0.9% of the administered TRH was recovered in the 3 h after TRH administration. Of the total urinary TRH recovered, 84.9% was excreted in the first 30 min. These results indicate that TRH is distributed in a large volume, that it is rapidly metabolized and that a significant quantity of administered TRH is excreted in the urine.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4198107      PMCID: PMC302433          DOI: 10.1172/JCI107339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Anatomy of body water and electrolytes.

Authors:  I S EDELMAN; J LEIBMAN
Journal:  Am J Med       Date:  1959-08       Impact factor: 4.965

2.  Thyrotropin secretion in genetically obese rats.

Authors:  D A York; J M Hershman; R D Utiger; G A Bray
Journal:  Endocrinology       Date:  1972-01       Impact factor: 4.736

Review 3.  Studies of thyrotropin physiology by means of radioimmunoassay.

Authors:  W D Odell; J F Wilber; R D Utiger
Journal:  Recent Prog Horm Res       Date:  1967

4.  Elimination of TRH in man.

Authors:  J Leppaluoto; P Virkkunen; H Lybeck
Journal:  J Clin Endocrinol Metab       Date:  1972-09       Impact factor: 5.958

5.  Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man.

Authors:  M S Anderson; C Y Bowers; A J Kastin; D S Schalch; A V Schally; P J Snyder; R D Utiger; J F Wilber; A J Wise
Journal:  N Engl J Med       Date:  1971-12-02       Impact factor: 91.245

6.  Site of inactivation of thyrotropin-releasing hormone by human plasma.

Authors:  R M Nair; T W Redding; A V Schally
Journal:  Biochemistry       Date:  1971-09-14       Impact factor: 3.162

7.  Triiodothyronine radioimmunoassay.

Authors:  J Lieblich; R D Utiger
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH).

Authors:  R Bassiri; R D Utiger
Journal:  Endocrinology       Date:  1972-09       Impact factor: 4.736

9.  The distribution of radioactivity following the administration of labeled thyrotropin-releasing hormone (TRH) in rats and mice.

Authors:  T W Redding; A V Schally
Journal:  Endocrinology       Date:  1971-10       Impact factor: 4.736

10.  Studies on the inactivation of thyrotropin-releasing hormone (TRH).

Authors:  T W Redding; A V Schally
Journal:  Proc Soc Exp Biol Med       Date:  1969-06
View more
  16 in total

1.  Low doses of TRH in amyotrophic lateral sclerosis and in other neurological diseases.

Authors:  S Congia; S Tronci; M Ledda; A Porcella; G Coppola
Journal:  Ital J Neurol Sci       Date:  1991-04

2.  TRH attenuates scopolamine-induced memory impairment in humans.

Authors:  S E Molchan; A M Mellow; B A Lawlor; H J Weingartner; R M Cohen; M R Cohen; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.

Authors:  Jayesh Kamath; Richard Feinn; Andrew Winokur
Journal:  Support Care Cancer       Date:  2011-09-27       Impact factor: 3.603

4.  Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

Authors:  J Møss; H Bundgaard
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

5.  Mathematical model of pituitary thyrotropic function.

Authors:  F J Seif
Journal:  Experientia       Date:  1977-09-15

6.  Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Authors:  A M Mellow; T Sunderland; R M Cohen; B A Lawlor; J L Hill; P A Newhouse; M R Cohen; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Authors:  John P Dougherty; Brian S Wolff; Mary J Cullen; Leorey N Saligan; Marvin C Gershengorn
Journal:  Pharmacol Res       Date:  2017-07-15       Impact factor: 7.658

8.  A kinetic study on secretion and elimination of endogenous thyrotropin in the thyrotropin-releasing hormone test.

Authors:  I Tsukamoto; K Satoh; K Kojima; I Hino; Y Kawase; H Seo; T Miyamoto; N Hosokawa; S Matsuno; T Tsukamoto
Journal:  Ann Nucl Med       Date:  1989-03       Impact factor: 2.668

9.  The effects of TRH analogues on cerebral ischaemia produced by middle cerebral artery occlusion in the rat.

Authors:  J Shrewsbury-Gee; R H Lye; A Latham; P Slater
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.